sales@scalarmarketresearch.com  |   +1-800-213-5170  (U.S./ Canada Toll-free)  |  REGISTER |  SIGN IN

Home >> Reports >> non invasive prenatal testing market

report

Non-Invasive Prenatal Testing Market, by Test (MaternilT21 PLUS, Bambni Test, informaSeq Prenatal Test, Harmony Prenatal Test, Non invasive Fetal Trisomy Test, Verifi, Prena Test), Gestation Period (0-12 Weeks, 13-24 Weeks, 25-36 Weeks), Pregnancy Risk (High & Average Risk, Low Risk) - Global Revenue, Trends, Growth, Share, Size, and Forecast to 2022

HC259 February 2017 100+ FREE 10% CUSTOMIZATION

Prenatal cell-free DNA screening is also known as non-invasive prenatal testing, is a technique to test for the certain specific chromosomal problem in a developing fetus. During the prenatal cell-free DNA testing, DNA from the fetus and mother is extracted from a motherly blood sample to test for the increased chance for specific chromosome abnormalities, such as Down syndrome. This test can also provide information about baby rhesus (Rh) blood type and sex. Non-invasive prenatal screening is recommended for women who are at least ten weeks pregnant.

The objective of this report on the non-invasive prenatal testing market is to comprehensively define and describe the growth trends and revenue forecasts for this market. It offers an in-depth analysis of the market share, segments, size, key players, and geographic regions. The report also focuses on the premium industry trends, technological advancements and innovative business strategies opted by the key players in this market.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the key factors propelling the growth of the global market
  • Information about the technological advancements influencing the growth of the global market
  • Detailed analysis of the regulatory environment impacting the growth of this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The non-invasive prenatal testing market is majorly driven by the rising incidences of Down syndrome around the world.
  • Additionally, increasing awareness of non-invasive prenatal testing is further expected to propel the market growth during the forecast period.
  • However, clinical validity of the tests on microdeletion is not yet established, which is likely to hinder the market growth to certain extent.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s non-invasive prenatal testing market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the non-invasive prenatal testing market by the following segments:

  • Non-Invasive Prenatal Testing Market, by Test
    • MaternilT21 PLUS
    • Bambni Test
    • informaSeq Prenatal Test
    • Harmony Prenatal Test
    • Non invasive Fetal Trisomy Test
    • Verifi
    • Prena Test
  • Non-Invasive Prenatal Testing Market, by Gestation Period
    • 0-12 weeks
    • 13-24 weeks
    • 25-36 weeks
  • Non-Invasive Prenatal Testing Market, by Risk Level
    • High & Average Risk
    • Low Risk

KEY MARKET PLAYERS

Key players in the non-invasive prenatal testing market include:

  • Sequenom.
  • Ariosa Diagnostics
  • Illumina, Inc.
  • Natera, Inc.
  • LifeCodexx AG
  • BGI Health
  • Berry Genomics
  • LabCorp

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K.
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Product Roadmap
  5. NON-INVASIVE PRENATAL TESTING MARKET, BY TEST
    1. Segment Share
    2. Test
      1. MaternilT21 PLUS
      2. Bambni Test
      3. informaSeq Prenatal Test
      4. Harmony Prenatal Test
      5. Non invasive Fetal Trisomy Test
      6. Verifi
      7. Prena Test
  6. NON-INVASIVE PRENATAL TESTING MARKET, BY GESTATION PERIOD
    1. Segment Share
    2. Gestation Period
      1. 0-12 weeks
      2. 13-24 weeks
      3. 25-36 weeks
  7. NON-INVASIVE PRENATAL TESTING MARKET, BY RISK LEVEL
    1. Segment Share
    2. Risk Level
      1. High & Average Risk
      2. Low Risk
  8. NON-INVASIVE PRENATAL TESTING MARKET, BY GEOGRAPHY
    1. North America
      1. By Country
        1. U.S.
        2. Rest of North America
      2. By Test
      3. By Gestation Period
      4. By Risk Level
    2. Europe
      1. By Country
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Test
      3. By Gestation Period
      4. By Risk Level
    3. Asia-Pacific
      1. By Country
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Test
      3. By Gestation Period
      4. By Risk Level
    4. Rest of the World
      1. By Country
        1. Latin America
        2. Middle East & Africa
      2. By Test
      3. By Gestation Period
      4. By Risk Level
  9. COMPETITIVE LANDSCAPE
    1. Market Share Analysis, 2015 (%)
    2. Key Innovators
  10. KEY MARKET PLAYERS
    1. Sequenom.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. Ariosa Diagnostics
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Illumina, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. Natera, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. LifeCodexx AG
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. BGI Health
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Berry Genomics
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. LabCorp
      1. Overview
      2. Key Strategies
      3. Recent Developments
  11. SCALAR 360 DEGREE MARKET PERSPECTIVE
  12. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170
EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

  • Unparalleled Expertise

    Our industry experts hold inimitable know-how across wide range of industry verticals

  • Assured Quality

    We deliver high-quality, real-time and data-driven industry insights to our clients

  • 24x7 Analyst Support

    We offer pre-purchase and post-purchase support from our industry experts

  • Privacy & Security

    All your personal information and confidential details are safe and secure with us